RAM
LGND icon

Riggs Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Riggs Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,964
Closed -$632K – 275
2016
Q4 		$632K Sell
9,964
-5,766
-37% -$364K 0.31% 43
2016
Q3 		$1M Buy
+15,730
New +$1.15M 0.52% 37

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Riggs Asset Management's LGND Position: Q1 2017 in Review

Riggs Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q1 2017, closing a stake of 9,964 shares — an estimated $632K sold.

Riggs Asset Management first reported a position in LGND in Q3 2016 and held it in 2 quarters. The position peaked at $1M in Q3 2016. 256 funds tracked by Wall St. Rank hold LGND as of Q1 2017.

  • Riggs Asset Management reported no remaining Ligand Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Riggs Asset Management sold 9,964 Ligand Pharmaceuticals shares in Q1 2017, an estimated $632K.
  • Riggs Asset Management first reported a position in Ligand Pharmaceuticals in Q3 2016 and held it in 2 quarters.
  • Riggs Asset Management's Ligand Pharmaceuticals position peaked at $1M in Q3 2016.
  • 256 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2017.

Based on Riggs Asset Management's 13F filing for Q1 2017, filed 1 May 2017.